• 1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 2. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Recent Advances in the Application of D-Leucine N-Carboxyanhydride (51018-87-2) in Chemical Biology and Pharmaceutical Research

D-Leucine N-Carboxyanhydride (NCA, CAS: 51018-87-2) has emerged as a pivotal building block in the synthesis of polypeptides and peptide-based materials, with significant implications for drug delivery, biomaterials, and therapeutic applications. Recent studies have highlighted its unique properties, including controlled polymerization kinetics and high reactivity, which make it an attractive candidate for precision polymer chemistry. This research briefing synthesizes the latest findings on D-Leucine NCA, focusing on its synthesis, characterization, and applications in the pharmaceutical and biomedical fields.

One of the key advancements in the use of D-Leucine NCA is its role in the development of biodegradable and biocompatible polymers. Researchers have demonstrated that the polymerization of D-Leucine NCA can be finely tuned to produce polypeptides with specific molecular weights and architectures, such as block copolymers and star-shaped polymers. These materials exhibit excellent stability and controlled release properties, making them ideal for targeted drug delivery systems. For instance, a 2023 study published in Biomacromolecules showcased the use of D-Leucine NCA-derived polymers for the encapsulation and sustained release of hydrophobic anticancer drugs.

In addition to drug delivery, D-Leucine NCA has been explored for its potential in creating bioactive surfaces and scaffolds for tissue engineering. The ability to functionalize polypeptides with various side chains allows for the incorporation of bioactive motifs, such as cell-adhesive peptides or growth factors. Recent work in Advanced Materials reported the fabrication of D-Leucine NCA-based hydrogels that support cell adhesion and proliferation, offering a promising platform for regenerative medicine applications.

Another notable area of research involves the enzymatic polymerization of D-Leucine NCA, which offers a greener alternative to traditional chemical methods. Enzymatic approaches using proteases or lipases have been shown to yield polypeptides with high enantiopurity and minimal byproducts. A 2024 study in ACS Catalysis detailed the optimization of enzymatic conditions for D-Leucine NCA polymerization, achieving high conversion rates and excellent control over polymer microstructure. This method aligns with the growing demand for sustainable and environmentally friendly synthetic processes in the pharmaceutical industry.

Despite these advancements, challenges remain in the large-scale production and commercialization of D-Leucine NCA-based materials. Issues such as monomer purity, polymerization reproducibility, and cost-effectiveness need to be addressed to facilitate broader adoption. Recent efforts have focused on improving synthetic protocols and scaling up production, as highlighted in a 2023 review article in Chemical Reviews. The development of novel catalysts and reaction conditions is expected to further enhance the efficiency and scalability of D-Leucine NCA polymerization.

In conclusion, D-Leucine N-Carboxyanhydride (51018-87-2) continues to be a versatile and valuable tool in chemical biology and pharmaceutical research. Its applications in drug delivery, tissue engineering, and sustainable polymer synthesis underscore its potential to address critical challenges in healthcare and materials science. Future research should prioritize the translation of laboratory findings into industrial applications, ensuring that the benefits of D-Leucine NCA-derived materials can be realized on a larger scale.

• 45895-90-7(L-Isoleucine N-Carboxyanhydride)
• 5860-61-7(2,5-Oxazolidinedione,4-(4-aminobutyl)-)
• 51248-35-2(4-Isobutyloxazolidine-2,5-dione)
• 45895-88-3((S)-4-(sec-Butyl)oxazolidine-2,5-dione)
• 1663-47-4((S)-Methyl 3-(2,5-dioxooxazolidin-4-yl)propanoate)
• 3190-70-3(N-Carboxyleucine Anhydride)
• 1676-88-6(4-Oxazolidinepropanoicacid, 2,5-dioxo-, methyl ester, (R)- (9CI))
• 5860-63-9(2,5-Oxazolidinedione,4-(1-methylpropyl)-)
• 78550-82-0(2,5-Oxazolidinedione,4-cyclohexyl-, (R)- (9CI))
• 6271-04-1(2,5-Oxazolidinedione,4-hexyl-)